The PPI network analysis identified MAPK1, HSP90AA1, MMP9, mTOR, ESR1, MAP2K1, PTGS2, EGFR, STAT3, and MAPK3 as potential core targets for CRP extract treatment of FD, which are closely related to inflammation. Here, MAPK1 is linked to Fabry disease.